TVTX – travere therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Travere Therapeutics (TVTX) had its price target lowered by JPMorgan Chase & Co. from $44.00 to $41.00. They now have an "overweight" rating on the stock.
Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli [Yahoo! Finance]
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX) [Yahoo! Finance]
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory [Yahoo! Finance]
Travere Therapeutics: FILSPARI Drives Revenue, FSGS PDUFA Looms [Seeking Alpha]
Form 4 Travere Therapeutics, For: Mar 16 Filed by: REED ELIZABETH E
Form 144 Travere Therapeutics, Filed by: REED ELIZABETH E
Form 4 Travere Therapeutics, For: Feb 20 Filed by: Dube Eric M
Form 144 Travere Therapeutics, Filed by: Dube Eric M
Form 10-K Travere Therapeutics, For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.